In addition, the TAK1 downstream IKKβ–P65 axis has been reported to be activated under insulin resistance in addition to liver steatosis [50]; it was shown that activation of the IKKβ–P65 axis was reduced by USP13 overexpression. Here, IKBKB is linked to fatty liver disease.